(Total Views: 212)
Posted On: 10/28/2022 11:02:10 AM
Post# of 25428
TCM treatment for Covid19 Patient - Regencell Bioscience $RGC
Regencell Bioscience’s Traditional Chinese Medicine (TCM) has treatment formula has so far treated 12 / 19 patients (suspected or confirmed COVID cases), and their health records showed improvements after an average treatment period of 5 days.
The company’s CEO and chairman noted “While the research is still ongoing, we strongly believe that our formula can make a difference in the fight against COVID-19."
The company’s current plan is to trade, manufacture, market and distrubte the TCM formulae for the treatment of COVID-19 to ASEAN countries, India, Japan, Australia and New Zealand.
Aside from the company’s positive progress in medical, the CEO (Mr Yat-Gai au) has shown his confidence in the progress of the company direction and has yet to sold a single share since taking the company IPO. Mr Yat has also pledged to refrain from taking salary and bonus (<1$) until the company reaches US$1 Billion market cap.
https://www.biospectrumasia.com/news/48/18957...tries.html
Regencell Bioscience’s Traditional Chinese Medicine (TCM) has treatment formula has so far treated 12 / 19 patients (suspected or confirmed COVID cases), and their health records showed improvements after an average treatment period of 5 days.
The company’s CEO and chairman noted “While the research is still ongoing, we strongly believe that our formula can make a difference in the fight against COVID-19."
The company’s current plan is to trade, manufacture, market and distrubte the TCM formulae for the treatment of COVID-19 to ASEAN countries, India, Japan, Australia and New Zealand.
Aside from the company’s positive progress in medical, the CEO (Mr Yat-Gai au) has shown his confidence in the progress of the company direction and has yet to sold a single share since taking the company IPO. Mr Yat has also pledged to refrain from taking salary and bonus (<1$) until the company reaches US$1 Billion market cap.
https://www.biospectrumasia.com/news/48/18957...tries.html
(0)
(0)
